204 related articles for article (PubMed ID: 38466127)
1. Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus.
Kim Y; Pool E; Kim E; Dampalla CS; Nguyen HN; Johnson DK; Lovell S; Groutas WC; Chang K-O
Microbiol Spectr; 2024 Apr; 12(4):e0337223. PubMed ID: 38466127
[TBL] [Abstract][Full Text] [Related]
2. Natural Phytochemicals, Luteolin and Isoginkgetin, Inhibit 3C Protease and Infection of FMDV, In Silico and In Vitro.
Theerawatanasirikul S; Thangthamniyom N; Kuo CJ; Semkum P; Phecharat N; Chankeeree P; Lekcharoensuk P
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834926
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
[TBL] [Abstract][Full Text] [Related]
4. Multiple-Site SUMOylation of FMDV 3C Protease and Its Negative Role in Viral Replication.
Wu X; Hu Y; Sui C; Pan L; Yoo D; Miller LC; Lee C; Cong X; Li J; Du Y; Qi J
J Virol; 2022 Sep; 96(17):e0061222. PubMed ID: 36005757
[TBL] [Abstract][Full Text] [Related]
5. Small Molecules Targeting 3C Protease Inhibit FMDV Replication and Exhibit Virucidal Effect in Cell-Based Assays.
Theerawatanasirikul S; Lueangaramkul V; Pantanam A; Mana N; Semkum P; Lekcharoensuk P
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766293
[TBL] [Abstract][Full Text] [Related]
6. Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development.
Puckette M; Clark BA; Smith JD; Turecek T; Martel E; Gabbert L; Pisano M; Hurtle W; Pacheco JM; Barrera J; Neilan JG; Rasmussen M
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878081
[TBL] [Abstract][Full Text] [Related]
7. Foot-and-Mouth Disease Virus 3C
Ekanayaka P; Weerawardhana A; Chathuranga K; Park JH; Lee JS
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146866
[TBL] [Abstract][Full Text] [Related]
8. Foot-and-Mouth Disease Virus Induces Porcine Gasdermin E-Mediated Pyroptosis through the Protease Activity of 3C
Ren X; Yin M; Zhao Q; Zheng Z; Wang H; Lu Z; Li X; Qian P
J Virol; 2023 Jul; 97(7):e0068623. PubMed ID: 37367489
[TBL] [Abstract][Full Text] [Related]
9. The Cellular Chaperone Heat Shock Protein 90 Is Required for Foot-and-Mouth Disease Virus Capsid Precursor Processing and Assembly of Capsid Pentamers.
Newman J; Asfor AS; Berryman S; Jackson T; Curry S; Tuthill TJ
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212943
[TBL] [Abstract][Full Text] [Related]
10. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
[TBL] [Abstract][Full Text] [Related]
11. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs.
Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus.
Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY
Molecules; 2019 May; 24(9):. PubMed ID: 31058822
[TBL] [Abstract][Full Text] [Related]
13. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
[TBL] [Abstract][Full Text] [Related]
14. Porcine Picornavirus 3C Protease Degrades PRDX6 to Impair PRDX6-mediated Antiviral Function.
Wang C; Feng H; Zhang X; Li K; Yang F; Cao W; Liu H; Gao L; Xue Z; Liu X; Zhu Z; Zheng H
Virol Sin; 2021 Oct; 36(5):948-957. PubMed ID: 33721217
[TBL] [Abstract][Full Text] [Related]
15. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
16. The antiviral response triggered by the cGAS/STING pathway is subverted by the foot-and-mouth disease virus proteases.
Sanz MÁ; Polo M; Rodríguez-Pulido M; Huildore Bommanna R; Sáiz M
Cell Mol Life Sci; 2024 Mar; 81(1):148. PubMed ID: 38509419
[TBL] [Abstract][Full Text] [Related]
17. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
[TBL] [Abstract][Full Text] [Related]
18. Insights into Polyprotein Processing and RNA-Protein Interactions in Foot-and-Mouth Disease Virus Genome Replication.
Pierce DM; Hayward C; Rowlands DJ; Stonehouse NJ; Herod MR
J Virol; 2023 May; 97(5):e0017123. PubMed ID: 37154761
[TBL] [Abstract][Full Text] [Related]
19. Nuclear ribonucleoprotein RALY downregulates foot-and-mouth disease virus replication but antagonized by viral 3C protease.
Wu J; Sun C; Guan J; Abdullah SW; Wang X; Ren M; Qiao L; Sun S; Guo H
Microbiol Spectr; 2024 Mar; 12(3):e0365823. PubMed ID: 38323828
[TBL] [Abstract][Full Text] [Related]
20. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
